China
· Delayed Price · Currency is CNY Cofoe Medical Technology Statistics
Total Valuation
SHE:301087 has a market cap or net worth of CNY 12.05 billion. The enterprise value is 10.47 billion.
| Market Cap | 12.05B |
| Enterprise Value | 10.47B |
Important Dates
The next confirmed earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
SHE:301087 has 230.20 million shares outstanding. The number of shares has decreased by -0.20% in one year.
| Current Share Class | 203.20M |
| Shares Outstanding | 230.20M |
| Shares Change (YoY) | -0.20% |
| Shares Change (QoQ) | +1.65% |
| Owned by Insiders (%) | 10.10% |
| Owned by Institutions (%) | 14.66% |
| Float | 82.74M |
Valuation Ratios
The trailing PE ratio is 28.92 and the forward PE ratio is 23.69. SHE:301087's PEG ratio is 1.40.
| PE Ratio | 28.92 |
| Forward PE | 23.69 |
| PS Ratio | 3.56 |
| PB Ratio | 2.46 |
| P/TBV Ratio | 2.86 |
| P/FCF Ratio | 23.28 |
| P/OCF Ratio | 17.32 |
| PEG Ratio | 1.40 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.28, with an EV/FCF ratio of 20.24.
| EV / Earnings | 28.19 |
| EV / Sales | 3.09 |
| EV / EBITDA | 20.28 |
| EV / EBIT | 31.31 |
| EV / FCF | 20.24 |
Financial Position
The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.17.
| Current Ratio | 2.41 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 1.60 |
| Debt / FCF | 1.60 |
| Interest Coverage | 20.82 |
Financial Efficiency
Return on equity (ROE) is 7.63% and return on invested capital (ROIC) is 9.21%.
| Return on Equity (ROE) | 7.63% |
| Return on Assets (ROA) | 3.20% |
| Return on Invested Capital (ROIC) | 9.21% |
| Return on Capital Employed (ROCE) | 6.64% |
| Weighted Average Cost of Capital (WACC) | 8.88% |
| Revenue Per Employee | 666,699 |
| Profits Per Employee | 73,137 |
| Employee Count | 5,081 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 2.43 |
Taxes
In the past 12 months, SHE:301087 has paid 55.53 million in taxes.
| Income Tax | 55.53M |
| Effective Tax Rate | 13.04% |
Stock Price Statistics
The stock price has increased by +60.21% in the last 52 weeks. The beta is 0.93, so SHE:301087's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | +60.21% |
| 50-Day Moving Average | 56.66 |
| 200-Day Moving Average | 46.64 |
| Relative Strength Index (RSI) | 42.18 |
| Average Volume (20 Days) | 3,016,519 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301087 had revenue of CNY 3.39 billion and earned 371.61 million in profits. Earnings per share was 1.81.
| Revenue | 3.39B |
| Gross Profit | 1.77B |
| Operating Income | 334.51M |
| Pretax Income | 425.84M |
| Net Income | 371.61M |
| EBITDA | 448.85M |
| EBIT | 334.51M |
| Earnings Per Share (EPS) | 1.81 |
Balance Sheet
The company has 2.44 billion in cash and 826.18 million in debt, giving a net cash position of 1.61 billion or 7.00 per share.
| Cash & Cash Equivalents | 2.44B |
| Total Debt | 826.18M |
| Net Cash | 1.61B |
| Net Cash Per Share | 7.00 |
| Equity (Book Value) | 4.90B |
| Book Value Per Share | 23.95 |
| Working Capital | 2.25B |
Cash Flow
In the last 12 months, operating cash flow was 695.73 million and capital expenditures -178.10 million, giving a free cash flow of 517.63 million.
| Operating Cash Flow | 695.73M |
| Capital Expenditures | -178.10M |
| Depreciation & Amortization | 114.33M |
| Net Borrowing | -164.27M |
| Free Cash Flow | 517.63M |
| FCF Per Share | 2.25 |
Margins
Gross margin is 52.20%, with operating and profit margins of 9.87% and 10.97%.
| Gross Margin | 52.20% |
| Operating Margin | 9.87% |
| Pretax Margin | 12.57% |
| Profit Margin | 10.97% |
| EBITDA Margin | 13.25% |
| EBIT Margin | 9.87% |
| FCF Margin | 15.28% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 3.33%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 3.33% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 100.04% |
| Buyback Yield | 0.20% |
| Shareholder Yield | 3.53% |
| Earnings Yield | 3.08% |
| FCF Yield | 4.30% |
Stock Splits
The last stock split was on May 20, 2022. It was a forward split with a ratio of 1.3000013.
| Last Split Date | May 20, 2022 |
| Split Type | Forward |
| Split Ratio | 1.3000013 |
Scores
SHE:301087 has an Altman Z-Score of 3.93 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.93 |
| Piotroski F-Score | 6 |